- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Family Size, Desired in Ireland
Total 1612 results
-
Novartis PharmaceuticalsCompletedBone Marrow Diseases | Hematologic Diseases | Blood Coagulation Disorders | Hemorrhagic Disorders | Primary Myelofibrosis | Myeloproliferative Disorders | Polycythemia Vera | Thrombocytosis | Essential Thrombocythemia | Blood Platelet DisordersUnited Kingdom, Belgium, Canada, France, Australia, Netherlands, Spain, Denmark, Ireland, Italy, Germany
-
ImmunoGen, Inc.Not yet recruitingRecurrent Ovarian Cancer | Folate Receptor-Alpha PositiveUnited States, Spain, Australia, Belgium, Canada, France, Ireland, Italy
-
National Cancer Institute (NCI)TerminatedStage III Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage II Rectal Cancer AJCC v8 | Locally Advanced Rectal CarcinomaUnited States
-
City of Hope Medical CenterNational Institutes of Health (NIH); National Institute on Aging (NIA)Active, not recruiting
-
Fondazione MichelangeloCompletedInvasive Ductal Breast CarcinomaSpain, Ireland, Italy, Taiwan, Germany, Austria, Russian Federation
-
European Organisation for Research and Treatment...CompletedLung CancerUnited Kingdom, Belgium, Netherlands, Italy, France
-
Boston Scientific CorporationCompletedNeoplasm MetastasisUnited States, France
-
[Redacted]Golden State DermatologyWithheldSkin Cancer | Skin Lesion | Skin Melanoma | Skin Cancer, Non-Melanoma | Skin Cancers - Squamous Cell Carcinoma | Skin Cancers - Basal Cell CarcinomaUnited States
-
Boston Scientific CorporationCompletedPain | Neoplasm Metastasis | Bone Metastasis of Diverse OriginsUnited States, France
-
AstraZenecaImaginAb, Inc.TerminatedCarcinoma, Non-Small-Cell Lung | Urinary Bladder Neoplasms | Colorectal CancerUnited States, Canada
-
IpsenCompletedMidgut Neuroendocrine Tumours | Pancreatic TumoursSpain, United Kingdom, Denmark, Belgium, Germany, France, Netherlands, Ireland, Italy, Poland
-
University of BirminghamUniversity of Oslo; University of Padova; Bambino Gesù Hospital and Research... and other collaboratorsRecruitingCarcinoma, Hepatocellular | HepatoblastomaUnited Kingdom, France, Austria, Belgium, Czechia, Germany, Ireland, Israel, Netherlands, Norway, Poland, Spain, Switzerland
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Ascenta TherapeuticsCompletedProstate CancerUnited States
-
European Organisation for Research and Treatment...Breast International Group; Menarini GroupRecruitingStage IIB Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Stage III Breast CancerBelgium, Italy, Ireland, France, Germany
-
BayerTerminatedCarcinoma, Renal CellItaly, Spain, France, Austria, Poland, United Kingdom, Ireland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedColorectal Cancer | Metastatic CancerUnited States
-
NovartisCompletedBreast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterUniversity of California, Los Angeles; Ferring Pharmaceuticals; Wayne State University and other collaboratorsCompleted
-
The Netherlands Cancer InstituteRecruitingOvarian CancerNetherlands, United States, France, Denmark, Italy, Sweden, Ireland
-
Numab Therapeutics AGRecruitingRenal Cell Carcinoma | Mesothelioma, Malignant | Adenocarcinoma of Lung | Triple Negative Breast Cancer | Endometrial Cancer | Fallopian Tube Carcinoma | Peritoneal Carcinoma | Leiomyosarcoma | Liposarcoma | Ovarian Carcinoma | Adenocarcinoma of the Stomach | Melanoma, Malignant | Adenocarcinoma - Gastroesophageal...United States
-
Kazia Therapeutics LimitedCompletedOvarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal NeoplasmsUnited States, Australia
-
Herbert Irving Comprehensive Cancer CenterUnknownBrain and Central Nervous System TumorsUnited States
-
Breast International GroupJules Bordet Institute; Frontier Science & Technology Research Foundation,...RecruitingMetastatic Breast CancerBelgium, Spain, Portugal, United Kingdom, Italy, Germany, Iceland, Luxembourg, Sweden, Switzerland
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI)CompletedLiver CancerUnited States
-
Dana-Farber Cancer InstituteMacroGenics; Translational Breast Cancer Research ConsortiumRecruitingBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage III Breast CancerUnited States
-
Boston Scientific CorporationRecruitingProstate CancerAustralia, Spain, United States, United Kingdom, Germany, Ireland, France, Italy, Switzerland
-
SanofiCompletedEndometrial Neoplasms | Endometrial CancerUnited States, Belgium
-
Merck KGaA, Darmstadt, GermanyCompletedBreast NeoplasmSpain, United Kingdom, Germany, Australia, Austria, Belgium, Israel, New Zealand, Portugal, Italy, Ireland
-
Dana-Farber Cancer InstituteTranslational Breast Cancer Research Consortium; Myriad Genetics, Inc.CompletedTriple Negative Breast CancerUnited States
-
Queen Mary University of LondonCancer Research UKCompletedBreast CancerFrance, Switzerland, Ireland, United Kingdom, Italy, Australia, Austria, Belgium, Chile, Germany, Hungary, Malta, Sweden, Turkey
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Wales Cancer Trials UnitCancer Research UKUnknownEsophageal CancerUnited Kingdom
-
University of BirminghamAstraZeneca; Cancer Trials IrelandActive, not recruitingOropharyngeal CancerUnited Kingdom, Ireland
-
CairnSurgical, Inc.SuspendedBreast Cancer FemaleUnited States, Canada, United Kingdom
-
AbbVieCompletedCancer | Advanced Solid Tumors | Hematologic MalignanciesUnited States, Japan, Netherlands, Spain
-
Incyte CorporationTerminatedProstate CancerUnited States
-
Artios Pharma LtdRecruitingMetastatic Cancer | Advanced Solid Tumor | Recurrent Endometrial CancerUnited States, France
-
Merck KGaA, Darmstadt, GermanyCompletedCarcinoma, Non-Small-Cell LungFrance, Italy, Poland, Spain, Germany, Belgium, Ireland, Czech Republic
-
National Cancer Institute (NCI)NRG OncologyWithdrawnRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian Carcinoma | Recurrent Fallopian Tube Endometrioid Adenocarcinoma | Recurrent Ovarian Endometrioid Adenocarcinoma | Recurrent Platinum-Resistant Fallopian Tube Carcinoma | Recurrent Platinum-Resistant Primary... and other conditionsUnited States
-
CelgeneTerminated
-
VA Office of Research and DevelopmentCompletedSkin Diseases | Carcinoma | Carcinoma, Squamous Cell | Carcinoma, Basal Cell | Neoplasms, Squamous Cell | Skin Neoplasms | Neoplasms, Basal CellUnited States
-
AbbVieTerminatedNon-small Cell Lung Cancer Stage IIIUnited States
-
Boston UniversityJohnson & Johnson; American College of Radiology Imaging NetworkRecruitingPulmonary DiseaseUnited States
-
GERCOR - Multidisciplinary Oncology Cooperative...Hoffmann-La RocheActive, not recruitingColorectal Cancer MetastaticIreland, France, Israel
-
Ronald HoffmanNational Cancer Institute (NCI); Roche Pharma AG; Myeloproliferative Disorders-Research...CompletedHigh Risk Polycythemia Vera | High Risk Essential ThrombocythemiaUnited States, Italy, United Kingdom, France
-
AbbottTerminatedNon-Small Cell Lung Cancer | Lung CancerUnited States, Canada, Ireland, United Kingdom
-
NCIC Clinical Trials GroupCompletedBreast CancerCanada, United States
-
UNICANCERBayerRecruitingProstate Cancer MetastaticSpain, France, Ireland, Belgium
-
UNICANCERCanadian Cancer Trials Group; GONO GROUPActive, not recruitingColon Cancer (High-risk Stage III: pT4N1 or pT1 to 4 N2)France, Canada